Correspondence

Total Page:16

File Type:pdf, Size:1020Kb

Correspondence CORRESPONDENCE New nomenclature for Fc receptor–like molecules To the editor: FCRL1 FCRL2 FCRL3 FCRL4 FCRL5 FCRL6 FCRLA FCRLB Newly identified Fc receptor–like genes are referred to in various publications as Fc recep- tor homologs (FcRH)1, immunoglobulin Human superfamily receptor translocation-associated genes (IRTA)2, immunoglobulin-Fc-gp42– related genes (IFGP)3, Src homology 2 domain– containing phosphatase anchor proteins (SPAP) or B cell crosslinked by anti–immuno- globulin M–activating sequences (BXMAS). http://www.nature.com/natureimmunology Prev ious Eight human and six mouse Fc receptor–like symbols : FcRH1 FcRH2 FcRH3 IRTA1 IRTA2 FcRH6 FCRL FcRL2 IRTA5 IRTA4 IRTA3 FcRH4 FcRH5 IFGP6 FREB FREB2 genes have been identified. Correspondence IFGP1 IFGP4 IFGP3 IFGP2 IFGP5 FcRX FcRY organized by the International Committee on BXMAS1 BXMAS2 BXMAS3 BXMAS SPAP1 SPAP2 Standardized Genetic Nomenclature for Mice, Accession the Mouse Genomic Nomenclature Committee number: NM_052938 NM_030764 NM_052939 NM_031282 NM_031281 NM_001004310 NM_032738 NM_001002901 and the Human Genome Organisation Gene Nomenclature Committee has emphasized FCRL1 FCRL5 FCRL6 FCRLS FCRLA FCRLB the need for a unified nomenclature to clas- sify these genes and has proposed the term Mouse ‘Fc receptor–like’ (‘FCRL’ or ‘Fcrl’). Nature Publishing Group Group Nature Publishing The chromosomal position and genomic 6 organization of ‘FCRL’ family is conserved 200 with that of the ‘classical’ Fc receptor (‘FCR’) © gene family. FCRL1–FCRL5 are tandemly located in the 1q21–23 region near FCGR1, Prev ious whereas FCRL6 is located closer to FCER1A. symbols : FcRH1 FcRH3 FcRH6 FcRH2 Fcrl1 Fcrl2 IFGP1 mBXMH2 IFGP2 FREB FREB2 FCRL1–FCRL6 encode type I transmem- BXMAS1 MSR2 FcRX FcRY Accession brane glycoproteins containing three to nine number: NM_153090 NM_183222 Unassigned NM_030707 NM_145141 NM_001029984 extracellular immunoglobulin domains and cytoplasmic immunoreceptor tyrosine-based Figure 1 Human and mouse Fc receptor–like proteins. Colors of immunoglobulin domains indicate activation–like motifs and/or immunoreceptor their phylogenetic relationships. Immunoreceptor tyrosine-based inhibition motifs, red boxes; immunoreceptor tyrosine-based activation–like motifs, green boxes; type B scavenger receptor cysteine- tyrosine-based inhibition motifs (Fig. 1, top). rich domain, gray box; mucin-rich regions, blue triangles. The first domain of FCRLA corresponds to a FCRL1 contains a charged residue in its trans- partial immunoglobulin domain and the full-length isoforms of both FCRLA and FCRLB are intracellular membrane region, but the transmembrane por- proteins. Accession numbers are for GenBank. tions of FCRL2–FCRL6 are hydrophobic and uncharged. FCRL1–FCRL5 are ‘preferentially’ expressed by B cells, whereas FCRL6 is expressed other ‘FCR’ and ‘FCRL’ genes. Both FcRL and FcRH3 are positioned near Fcgr1 on chro- mainly by T cells and natural killer cells. FcRL2 are expressed by B cells as well as non- mosome 3 and encode proteins containing Two additional human ‘FCRL’ genes, origi- lymphoid cells and encode immunoglobulin- two to five immunoglobulin domains with nally called FcRL (also known as FREB or FcRX) like molecules that lack transmembrane regions or without transmembrane regions5 (Fig. 1, and FcRL2 (also known as FREB2 or FcRY)4, and tyrosine-based signaling motifs, but dis- bottom). FcRH1 and FcRH3 are expressed have unusual features that justify their desig- tinctly have C-terminal mucin-like regions. by B cells and encode molecules containing nation as a separate subfamily. These genes are The nomenclature we suggest for these genes is cytoplasmic tyrosine-based signaling motifs. located in the low-affinity ‘FCR’ locus on chro- FCRLA (for FcRL) and FCRLB (for FcRL2). Uniquely, FcRH2 does not cluster with FcRH1 mosome 1q23 and contain two or three immu- The mouse ‘Fcr’ locus is divided between and FcRH3, lacks a human ortholog or lym- noglobulin domains (Fig. 1, top). However, chromosomes 1 and 3. The genes origi- phoid expression and encodes a molecule FcRL lacks exons encoding a split signal pep- nally called FcRH1 (also known as Ifgp1), containing a C-terminal type B scavenger tide, a genomic organization characteristic of FcRH2 (also known as Ifgp2 and Msr2) and receptor cysteine-rich domain without a NATURE IMMUNOLOGY VOLUME 7 NUMBER 5 MAY 2006 431 CORRESPONDENCE transmembrane region. We support the identified. We propose the designation ‘v’ fol- 1Mouse Genome Informatics Resource, MGD assignment of the symbol Fcrl1 for the gene lowed by a number, such as Fcrl1_v1, to des- Nomenclature Group, Jackson Laboratory, previously known as FcRH1 and the symbol ignate splice variants. As cluster designations Bar Harbor, Maine 04609, USA. 2 Fcrl5 for the gene previously known as FcRH3 are assigned, we anticipate modifications of Human Genome Organisation Gene (given its sequence identity and surrounding the nomenclature to accommodate this new Nomenclature Committee, Galton Laboratory, University College London, London NW1 2HE, genomic homology) and propose the symbol extended receptor family. UK. Fcrls for FcRH2 (to emphasize that it has a 3 1. Davis, R.S., Wang, Y.H., Kubagawa, H. & Cooper, M.D. Institute of Cytology and Genetics, Novosibirsk scavenger receptor cysteine-rich motif). Proc. Natl. Acad. Sci. USA 98, 9772–9777 (2001). 630090, Russia. Three additional mouse ‘Fcrl’ genes are 2. Hatzivassiliou, G. et al. Immunity 14, 277–289 4Department of Pathology and Immunology, (2001). located near the low-affinity ‘Fcr’ locus on 3. Guselnikov, S.V. et al. Immunogenetics 54, 87–95 Washington University School of Medicine, mouse chromosome 1. FcRH6, FcRL (also (2002). St. Louis, Missouri 63110, USA. known as Freb and FcRX) and FcRL2 (also 4. Mechetina, L.V. et al. Eur. J. Immunol. 32, 87–96 5Laboratory of Molecular Genetics and (2002). known as Freb2 and FcRY) are located in syn- Immunology, Rockefeller University, New York, 5. Davis, R.S., Stephan, R.P., Chen, C.C., Dennis, G., Jr. & New York 10021, USA. tenic regions relative to their human ortho- Cooper, M.D. Int. Immunol. 16, 1343–1353 (2004). 6Institute for Cancer Genetics, Columbia logs. The new names we suggest for these genes University, New York, New York 10032, USA. are Fcrl6, Fcrla and Fcrlb, respectively. Lois J Maltais1, Ruth C Lovering2, Alexander V 7Division of Developmental and Clinical Expression patterns, functions and ligands Taranin3, Marco Colonna4, Jeffrey V Ravetch5, Immunology, University of Alabama at of Fc receptor-like molecules are being inves- Riccardo Dalla-Favera6, Peter D Burrows7, Birmingham, Birmingham, Alabama 35294, USA. tigated and additional splice isoforms may be Max D Cooper7 & Randall S Davis7 e-mail: [email protected] http://www.nature.com/natureimmunology Nature Publishing Group Group Nature Publishing 6 200 © 432 VOLUME 7 NUMBER 5 MAY 2006 NATURE IMMUNOLOGY.
Recommended publications
  • This Is an Author Produced Version of a Paper Published in Immunology
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Publications from Karolinska Institutet This is an author produced version of a paper published in Immunology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Pubmed citation for the paper: Immunology. 2014 May 6. [Epub ahead of print] Ligation of human Fc receptor like-2 (FCRL2) by monoclonal antibodies downregulates B cell receptor mediated signaling. Shabani M, Bayat AA, Jeddi-Tehrani M, Rabbani H, Hojjat-Farsangi M, Ulivieri C, Amirghofran Z, Baldari CT, Shokri F. URL: http://dx.doi.org/10.1111/imm.12311 Access to the published version may require subscription. Published with permission from: Wiley Ligation of human Fc receptor like-2 (FCRL2) by monoclonal antibodies downregulates B cell receptor mediated signaling Mahdi Shabania,b, Ali Ahmad Bayata, Mahmood Jeddi-Tehrania, Hodjatallah Rabbania,c, Mohammad Hojjat-Farsangid, Cristina Ulivierie, Zahra Amirghofranb, Cosima Tatiana Baldarie and Fazel Shokria,f* a Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran b Department of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran c Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden d Immune and Gene Therapy Laboratory, Cancer Centre Karolinska, Department of Oncology-Pathology, Karolinska Institutet, Stockholm e Department of Life Sciences, University of Siena, Siena, Italy f Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran *Corresponding author: Fazel Shokri, Ph.D., Professor, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, P.O.
    [Show full text]
  • The Genomic Organization and Expression Pattern of the Low-Affinity Fc Gamma Receptors (Fcγr) in the Göttingen Minipig
    Immunogenetics (2019) 71:123–136 https://doi.org/10.1007/s00251-018-01099-1 ORIGINAL ARTICLE The genomic organization and expression pattern of the low-affinity Fc gamma receptors (FcγR) in the Göttingen minipig Jerome Egli1 & Roland Schmucki1 & Benjamin Loos1 & Stephan Reichl1 & Nils Grabole1 & Andreas Roller1 & Martin Ebeling1 & Alex Odermatt2 & Antonio Iglesias1 Received: 9 August 2018 /Accepted: 24 November 2018 /Published online: 18 December 2018 # The Author(s) 2018 Abstract Safety and efficacy of therapeutic antibodies are often dependent on their interaction with Fc receptors for IgG (FcγRs). The Göttingen minipig represents a valuable species for biomedical research but its use in preclinical studies with therapeutic antibodies is hampered by the lack of knowledge about the porcine FcγRs. Genome analysis and sequencing now enabled the localization of the previously described FcγRIIIa in the orthologous location to human FCGR3A. In addition, we identified nearby the gene coding for the hitherto undescribed putative porcine FcγRIIa. The 1′241 bp long FCGR2A cDNA translates to a 274aa transmembrane protein containing an extracellular region with high similarity to human and cattle FcγRIIa. Like in cattle, the intracellular part does not contain an immunoreceptor tyrosine-based activation motif (ITAM) as in human FcγRIIa. Flow cytometry of the whole blood and single-cell RNA sequencing of peripheral blood mononuclear cells (PBMCs) of Göttingen minipigs revealed the expression profile of all porcine FcγRs which is compared to human and mouse. The new FcγRIIa is mainly expressed on platelets making the minipig a good model to study IgG-mediated platelet activation and aggregation. In contrast to humans, minipig blood monocytes were found to express inhibitory FcγRIIb that could lead to the underestimation of FcγR-mediated effects of monocytes observed in minipig studies with therapeutic antibodies.
    [Show full text]
  • Elements of Immunoglobulin E Network Associate with Aortic Valve Area in Patients with Acquired Aortic Stenosis
    biomedicines Communication Elements of Immunoglobulin E Network Associate with Aortic Valve Area in Patients with Acquired Aortic Stenosis Daniel P. Potaczek 1,2,† , Aleksandra Przytulska-Szczerbik 2,†, Stanisława Bazan-Socha 3 , Artur Jurczyszyn 4, Ko Okumura 5, Chiharu Nishiyama 6, Anetta Undas 2,7,‡ and Ewa Wypasek 2,8,*,‡ 1 Translational Inflammation Research Division & Core Facility for Single Cell Multiomics, Medical Faculty, Philipps University Marburg, Member of the German Center for Lung Research (DZL) and the Universities of Giessen and Marburg Lung Center, 35043 Marburg, Germany; [email protected] 2 Krakow Center for Medical Research and Technology, John Paul II Hospital, 31-202 Krakow, Poland; [email protected] (A.P.-S.); [email protected] (A.U.) 3 Department of Internal Medicine, Jagiellonian University Medical College, 31-066 Krakow, Poland; [email protected] 4 Department of Hematology, Jagiellonian University Medical College, 31-501 Krakow, Poland; [email protected] 5 Atopy Research Center, Juntendo University School of Medicine, Tokyo 113-8421, Japan; [email protected] 6 Laboratory of Molecular Biology and Immunology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585, Japan; [email protected] 7 Institute of Cardiology, Jagiellonian University Medical College, 31-202 Krakow, Poland 8 Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, 30-705 Krakow, Poland * Correspondence: [email protected]; Tel.: +48-12-614-31-35 † These first authors contributed equally to this work. ‡ These last authors contributed equally to this work. Abstract: Allergic mechanisms are likely involved in atherosclerosis and its clinical presentations, Citation: Potaczek, D.P.; Przytulska-Szczerbik, A.; Bazan-Socha, such as coronary artery disease (CAD).
    [Show full text]
  • Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition 12-19-2010 Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P. Stewart Marshall University Hyoung Y. Kim University of Tennessee - Knoxville, [email protected] Arnold M. Saxton University of Tennessee - Knoxville, [email protected] Jung H. Kim Marshall University Follow this and additional works at: https://trace.tennessee.edu/utk_nutrpubs Part of the Animal Sciences Commons, and the Nutrition Commons Recommended Citation BMC Genomics 2010, 11:713 doi:10.1186/1471-2164-11-713 This Article is brought to you for free and open access by the Nutrition at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Nutrition Publications and Other Works by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Stewart et al. BMC Genomics 2010, 11:713 http://www.biomedcentral.com/1471-2164/11/713 RESEARCH ARTICLE Open Access Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P Stewart1, Hyoung Yon Kim2, Arnold M Saxton3, Jung Han Kim1* Abstract Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/ JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake and tolerance, hyperlipidemia, and hyperglycemia.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Rabbit Anti-FCRL1 Antibody-SL16064R
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-FCRL1 antibody SL16064R Product Name: FCRL1 Chinese Name: CD307a抗体 CD307a; Fc receptor homolog 1; Fc receptor like protein 1; Fc receptor-like protein 1; FcR like protein 1; FcR-like protein 1; FCRH 1; FcRH1; FCRL 1; FcRL1; FCRL1_HUMAN; hIFGP 1; hIFGP1; IFGP 1; IFGP family protein 1; IFGP1; Immune Alias: receptor translocation associated protein 5; Immune receptor translocation-associated protein 5; immunoglobulin superfamily Fc receptor, gp42; IRTA 5; IRTA5; RP11 367J7.7. Organism Species: Rabbit Clonality: Polyclonal React Species: Human, WB=1:500-2000ELISA=1:500-1000IHC-P=1:400-800IHC-F=1:400-800ICC=1:100- 500IF=1:100-500(Paraffin sections need antigen repair) Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 45kDa Cellular localization: The cell membrane Form: Lyophilizedwww.sunlongbiotech.com or Liquid Concentration: 1mg/ml KLH conjugated synthetic peptide derived from human FCRL1:251- immunogen: 350/429<Extracellular> Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    [Show full text]
  • Mouse Fcrla Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Fcrla Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Fcrla conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Fcrla gene (NCBI Reference Sequence: NM_001160215 ; Ensembl: ENSMUSG00000038421 ) is located on Mouse chromosome 1. 5 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 5 (Transcript: ENSMUST00000046322). Exon 2~4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Fcrla gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-100H5 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a targeted allele exhibit largely normal T-dependent and T-independent antibody responses with an increase in IgG1 after secondary challenge with sheep red blood cells. Exon 2~4 is not frameshift exon, and covers 69.69% of the coding region. The size of intron 1 for 5'-loxP site insertion: 5054 bp, and the size of intron 4 for 3'-loxP site insertion: 2439 bp. The size of effective cKO region: ~2074 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Fcrla Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Microarray Analysis of Novel Genes Involved in HSV- 2 Infection
    Microarray analysis of novel genes involved in HSV- 2 infection Hao Zhang Nanjing University of Chinese Medicine Tao Liu ( [email protected] ) Nanjing University of Chinese Medicine https://orcid.org/0000-0002-7654-2995 Research Article Keywords: HSV-2 infection,Microarray analysis,Histospecic gene expression Posted Date: May 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-517057/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: Herpes simplex virus type 2 infects the body and becomes an incurable and recurring disease. The pathogenesis of HSV-2 infection is not completely clear. Methods: We analyze the GSE18527 dataset in the GEO database in this paper to obtain distinctively displayed genes(DDGs)in the total sequential RNA of the biopsies of normal and lesioned skin groups, healed skin and lesioned skin groups of genital herpes patients, respectively.The related data of 3 cases of normal skin group, 4 cases of lesioned group and 6 cases of healed group were analyzed.The histospecic gene analysis , functional enrichment and protein interaction network analysis of the differential genes were also performed, and the critical components were selected. Results: 40 up-regulated genes and 43 down-regulated genes were isolated by differential performance assay. Histospecic gene analysis of DDGs suggested that the most abundant system for gene expression was the skin, immune system and the nervous system.Through the construction of core gene combinations, protein interaction network analysis and selection of histospecic distribution genes, 17 associated genes were selected CXCL10,MX1,ISG15,IFIT1,IFIT3,IFIT2,OASL,ISG20,RSAD2,GBP1,IFI44L,DDX58,USP18,CXCL11,GBP5,GBP4 and CXCL9.The above genes are mainly located in the skin, immune system, nervous system and reproductive system.
    [Show full text]
  • GATA2 Regulates Mast Cell Identity and Responsiveness to Antigenic Stimulation by Promoting Chromatin Remodeling at Super- Enhancers
    ARTICLE https://doi.org/10.1038/s41467-020-20766-0 OPEN GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super- enhancers Yapeng Li1, Junfeng Gao 1, Mohammad Kamran1, Laura Harmacek2, Thomas Danhorn 2, Sonia M. Leach1,2, ✉ Brian P. O’Connor2, James R. Hagman 1,3 & Hua Huang 1,3 1234567890():,; Mast cells are critical effectors of allergic inflammation and protection against parasitic infections. We previously demonstrated that transcription factors GATA2 and MITF are the mast cell lineage-determining factors. However, it is unclear whether these lineage- determining factors regulate chromatin accessibility at mast cell enhancer regions. In this study, we demonstrate that GATA2 promotes chromatin accessibility at the super-enhancers of mast cell identity genes and primes both typical and super-enhancers at genes that respond to antigenic stimulation. We find that the number and densities of GATA2- but not MITF-bound sites at the super-enhancers are several folds higher than that at the typical enhancers. Our studies reveal that GATA2 promotes robust gene transcription to maintain mast cell identity and respond to antigenic stimulation by binding to super-enhancer regions with dense GATA2 binding sites available at key mast cell genes. 1 Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO 80206, USA. 2 Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, USA. 3 Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, ✉ CO 80045, USA. email: [email protected] NATURE COMMUNICATIONS | (2021) 12:494 | https://doi.org/10.1038/s41467-020-20766-0 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20766-0 ast cells (MCs) are critical effectors in immunity that at key MC genes.
    [Show full text]
  • Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas
    Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate)
    [Show full text]